# Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/neoadjuvant-chemotherapy-endocrine-therapy-and-targeted-therapy-for-breast-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nina Tamirisa,Kelly K. Hunt |
| Citations | 54 |
| DOI | 10.1245/s10434-021-11223-3 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4225665873 |
| PMID | 34989940 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Nina Tamirisa](https://scholariq.org/researchers/nina-tamirisa/)

## Paper journal

- [Annals of Surgical Oncology](https://scholariq.org/journals/annals-of-surgical-oncology/)

## Paper primary topic

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Paper topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.